Defining and Measuring Quality in Cancer Care

Sep 12 2019

Clock icon WHEN:

Sep 12, 2019 at 9:30am

Where icon WHERE:

Ballroom

User icon CONTACT INFO:
Info icon MORE INFO:

Meeting

The National Comprehensive Cancer Network® (NCCN®) hosts a policy summit on challenges and promising practices for measuring quality cancer care delivery with a look toward the future. Join the conversation online with the hashtag #NCCNPolicy. What NCCN Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care The summit will explore the application and measurement of quality in cancer care delivery systems, and the future of defining, standardizing, and reporting quality in cancer care. When Thursday, September 12th | 9:30 AM – 3:00 PM (Breakfast at 8:30 AM) Where The National Press Club – 13th Floor 529 14th Street NW Washington, D.C. Who Introduction: Wui-Jin Koh, MD Chief Medical Officer, NCCN Panel Moderation: Clifford Goodman, PhD Senior Vice President, The Lewin Group Address on defining and measuring quality under current value-based care models: Kerin Adelson, MD Chief Quality Officer and Deputy Chief Medical Officer, Smilow Cancer Hospital Diana Verrilli, MPH VP/GM of Managed Care, Quality & Provider Solutions, McKesson Specialty Health Address on the role of standardized performance measures in ensuring quality in cancer care: Shantanu Agrawal, MD, MPhil CEO, National Quality Forum (NQF) Additional Panelists include: Alan Balch, PhD CEO National Patient Advocate Foundation Alexandra Chong, PhD OCM Team Lead Centers for Medicare & Medicaid Services (CMS) Reena Duseja, MD, MS Chief Medical Officer for Quality Measurement Centers for Medicare & Medicaid Services (CMS) Nancy Keating, MD, MPH Professor of Health Care Policy & Medicine Harvard Medical School Bryan Loy, MD, MBA Physician Lead – Oncology, Laboratory, and Personalized Medicine Humana Jim Martineau, MBA Director, Product Management & Operations Flatiron Kashyap Patel, MD Oncologist, Managing Partner Carolina Blood and Cancer Care Gaurav Singal, MD Chief Data Officer Foundation Medicine Lawrence N. Shulman, MD Deputy Director for Clinical Services Abramson Cancer Center at the University of Pennsylvania Jacqueline Waldrop, MS Director, Oncology Grant Officer Pfizer, Inc. Ronald S. Walters, MD, MBA, MHA, MS Associate Head for the Institute for Cancer Care Innovation The University of Texas MD Anderson Cancer Center Chair NCCN Board of Directors Tracy Wong, MBA Director, Quality and Value Seattle Cancer Care Alliance For more information and the full agenda, visit NCCN.org/policy. Take part in the online discussion with the hashtag #NCCNPolicy. To request a complimentary press pass, contact Rachel Darwin at [email protected] or 267-622-6624. # # # About the National Comprehensive Cancer Network The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 28 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world. Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients. Media, visit NCCN.org/news. Follow NCCN on Twitter @NCCN, Facebook @NCCNorg, and Instagram @NCCNorg.